Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Reply to De Nunzio, Franco, and Lombardo

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. De Nunzio C, Franco A, Lombardo R. LUTS/BPH and SARS-COV2: when a misunderstanding in the correct physiopathology results in incorrect associations. Prostate Cancer Prostatic Dis. 2021. https://doi.org/10.1038/s41391-021-00419-z.

  2. Haghpanah A, Masjedi F, Salehipour M, Hosseinpour A, Roozbeh J, Dehghani A. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review. Prostate Cancer Prostatic Dis. 2021. https://doi.org/10.1038/s41391-021-00388-3.

  3. Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect, Genet Evolut. 2021;87:104647. https://doi.org/10.1016/j.meegid.2020.104647.

    Article  CAS  Google Scholar 

  4. Can O, Erkoç M, Ozer M, Karakanli MU, Otunctemur A. The effect of COVID-19 on lower urinary tract symptoms in elderly men. Int J Clin Pract. 2021;75:e14110. https://doi.org/10.1111/ijcp.14110.

    Article  CAS  PubMed  Google Scholar 

  5. Cinislioglu AE, Demirdogen SO, Cinislioglu N, Altay MS, Sam E, Akkas F, et al. Variation of serum PSA levels in COVID-19 infected male patients with benign prostatic hyperplasia (BPH): a prospective cohort study. Urology. 2021. https://doi.org/10.1016/j.urology.2021.09.016.

Download references

Author information

Authors and Affiliations

Authors

Contributions

A Ha, and FM made substantial contributions to discussions of content, FM and A Ho wrote the article, and AD reviewed and edited the manuscript before submission.

Corresponding author

Correspondence to Fatemeh Masjedi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haghpanah, A., Masjedi, F., Hosseinpour, A. et al. Reply to De Nunzio, Franco, and Lombardo. Prostate Cancer Prostatic Dis 25, 129 (2022). https://doi.org/10.1038/s41391-021-00476-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41391-021-00476-4

Search

Quick links